Reviewing Veeva Systems (NYSE:VEEV) & GoodRx (NASDAQ:GDRX)

Veeva Systems (NYSE:VEEV) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Valuation & Earnings

This table compares Veeva Systems and GoodRx”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veeva Systems	$3.20 billion	12.51	$908.91 million	$5.61	43.88
GoodRx	$796.85 million	1.51	$30.44 million	$0.04	87.88

Veeva Systems has higher revenue and earnings than GoodRx. Veeva Systems is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Veeva Systems and GoodRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Veeva Systems	28.37%	13.72%	11.31%
GoodRx	2.07%	7.22%	2.53%

Institutional and Insider Ownership

88.2% of Veeva Systems shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 10.6% of Veeva Systems shares are held by insiders. Comparatively, 5.9% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Volatility and Risk

Veeva Systems has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Veeva Systems and GoodRx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veeva Systems	1	8	19	0	2.64
GoodRx	3	6	4	0	2.08

Veeva Systems presently has a consensus target price of $258.08, indicating a potential upside of 4.85%. GoodRx has a consensus target price of $4.23, indicating a potential upside of 20.26%. Given GoodRx’s higher probable upside, analysts clearly believe GoodRx is more favorable than Veeva Systems.

Summary

Veeva Systems beats GoodRx on 11 of the 14 factors compared between the two stocks.

About Veeva Systems

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

About GoodRx

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.